Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative imatinib plasma concentration study in giant gastrointestinal stromal tumors
ChiCTR-OPC-15006846Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by West China Hospital of Sichuan University. Primary endpoints: Plasma concentration of imatinib and Clinical efficacy. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR-OPC-15006846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006846.